Risnia MD 3 Tablet
Marketer
Cipla Ltd
Salt Composition
Risperidone (3mg)
Overview Risnia MD 3 Tablet
Risnia MD 3 Tablet treats schizophrenia (a mental illness causing hallucinations, delusions, and impaired thinking/behavior) and mania. Administer this tablet with or without food, ideally at bedtime, but consistently at the same time daily for optimal blood levels. Follow your doctor's prescribed dosage and duration. If a dose is missed, take it immediately upon recall. Sudden cessation is unsafe and may exacerbate symptoms; consult your doctor before stopping. Immediately discontinue if Neuroleptic malignant syndrome (NMS) occurs (fever, muscle stiffness, altered awareness, or seizures). Common side effects include sleep disturbances (insomnia, sedation, somnolence), vomiting, cough, Parkinsonian symptoms, headache, and fever. Postural hypotension (sudden blood pressure drop upon standing) may initially occur; rise slowly. Dizziness and drowsiness are possible; avoid driving or mentally demanding tasks until effects are known. Weight gain is a potential side effect, mitigated by diet and exercise. Increased diabetes risk exists; regular glucose monitoring is advised. Report any unusual mood shifts, new/worsening depression, or suicidal ideation to your physician.
Primary Ingredients of Risnia MD 3 Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Risnia MD 3 Tablet
Managing Manic Episodes | Managing Schizophrenia
Major Benefits of Risnia MD 3 Tablet:
Administer this medication precisely as your physician directs, adhering to both dosage and treatment length. Avoid handling the tablets with damp hands. Place the tablet in your mouth; however, refrain from swallowing immediately. Risnia MD 3 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Risnia MD 3 Tablet:
- Headache
- Insomnia (difficulty in sleeping)
- Parkinsonism
- Drowsiness
- Sedation
- Vomiting
- Increased saliva production
- Cough
- Urinary tract infection
How to use Risnia MD 3 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth, but refrain from immediate swallowing. Risnia MD 3 Tablet can be ingested with or without food; however, consistent timing is recommended.
How Risnia MD 3 Tablet works:
Risnia MD 3 Tablet is classified as an atypical antipsychotic medication. Its mechanism of action involves modulating neurotransmitter levels, specifically dopamine and serotonin, to positively influence mood, cognitive function, and behavior.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Risnia MD 3 Tablet and alcohol can lead to significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Risnia MD 3 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Use of Risnia MD 3 Tablet while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Risnia MD 3 Tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Risnia MD 3 Tablet. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Risnia MD 3 Tablet; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Risnia MD 3 Tablet :
Should you forget a Risnia MD 3 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Risnia MD 3 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzisoxazole-based compound |
| Developing Habits | No. |
| Type of Therapy | Central Nervous System (CNS) Neurology |
3,018 People bought this recently